您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2017, Vol. 55 ›› Issue (6): 108-113.doi: 10.6040/j.issn.1671-7554.0.2017.341

• • 上一篇    下一篇

基于社区2型糖尿病患者的心脑血管事件5年风险预测模型

张振堂1,杨洋2,3,韩福俊1,陈向华1,季晓康3,4,王永超3,5,王淑康2,3,孙苑潆2,3,李敏2,3,陈亚飞2,3,王丽6,薛付忠2,3,刘言训2,3   

  1. 1.青岛市黄岛区疾病预防控制中心, 山东 青岛 266400;2.山东大学公共卫生学院生物统计系, 山东 济南 250012;3.山东大学齐鲁生物医学大数据研究中心, 山东 济南 250012;4.山东大学公共卫生学院信息处理实验室, 山东 济南 250012;5.康评健康医疗大数据科技有限公司, 山东 济南 250101;6.山东电力中心医院心内科, 山东 济南 250001
  • 收稿日期:2017-04-19 出版日期:2017-06-10 发布日期:2017-06-10
  • 通讯作者: 刘言训. E-mail: liu-yx@sdu.edu.cn E-mail:liu-yx@sdu.edu.cn
  • 基金资助:
    国家自然科学基金青年基金(81400072);山东省自然科学基金(2013HQ047)

A prediction model of 5-year CVD risks for type 2 diabetic patients: a prospective cohort study among Chinese community population

ZHANG Zhentang1, YANG Yang2,3, HAN Fujun1, CHEN Xianghua1, JI Xiaokang3,4, WANG Yongchao3,5, WANG Shukang2,3, SUN Yuanying2,3, LI Min2,3, CHEN Yafei2,3, WANG Li6, XUE Fuzhong2,3, LIU Yanxun2,3   

  1. 1. Center for Disease Control and Prevention of Huangdao District, Qingdao 266400, Shandong, China;
    2. Department of Biostatistics, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    3. Cheeloo Research Center for Biomedical Big Data, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    4. Information Processing Laboratory, School of Public Health, Shandong University, Jinan 250012, Shandong, China;
    5. Kangping Health Care Big Data Technology Company Limited, Jinan 250101, Shandong, China;
    6. Department of Cardiology, Shandong Electric Power Central Hospital, Jinan 250001, Shandong, China
  • Received:2017-04-19 Online:2017-06-10 Published:2017-06-10

摘要: 目的 构建新诊断的2型糖尿病患者5年内首次发生心脑血管事件的预测模型。 方法 研究对象选自青岛市黄岛区疾病预防控制中心慢性病管理系统,选择未发生过心脑血管事件的2型糖尿病患者2 899例作为训练样本,建立Cox模型和评分模型,并对模型进行内部验证;用“山东多中心健康管理纵向观察队列”中的1 016例2型糖尿病患者作为验证样本,对模型进行外部验证。 结果 随访期间训练样本共发生228例心脑血管事件,发病密度为16.86‰。模型变量包括年龄、性别、收缩压、低密度脂蛋白、高密度脂蛋白和心脑血管病家族史。训练样本Cox模型ROC曲线下面积(AUC)为0.678(95%CI:0.660~0.695),评分模型AUC为0.663(95%CI:0.648~0.680);外部验证Cox模型AUC为0.640(95%CI:0.608~0.676),评分模型AUC为0.631(95%CI:0.600~0.661)。 结论 研究建立的2型糖尿病患者心脑血管事件5年预测模型可以为社区糖尿病患者管理初期提供参考。

关键词: 糖尿病, 社区管理, 并发症, 心脑血管病, 预测模型

Abstract: Objective To construct a prediction model for risks of cardio-cerebrovascular disease(CVD)in 5 years for newly diagnosed type 2 diabetic patients in China. Methods We collected from an official chronic disease prevention and control project 2 899 participants newly diagnosed as diabetic who were free from CVD events. Cox proportional 山 东 大 学 学 报 (医 学 版)55卷6期 -张振堂,等.基于社区2型糖尿病患者的心脑血管事件5年风险预测模型 \=-hazards regression model was used to construct a 5-year CVD risk model. Calibration and goodness of fit test were applied. External validation based on Shandong Multi-center Health Management Large Database was adopted to assess the stability of model. Results a total of 228 first CVD events were recorded in the derivation cohort during an average follow-up of 4.7 years(16.86/1 000 person-year). The 6 variables included age, gender, systolic pressure, low-density lipoprotein, high-density lipoprotein and family history of CVD. In the derivation cohort, the area under the receiver operating characteristic curve(AUC)for the Cox model and scoring model was 0.678(95%CI: 0.660-0.695)and 0.663(95%CI: 0.648-0.680), respectively. In the external validation, the AUC for the Cox model and scoring model was 0.640(95%CI: 0.608-0.676)and 0.631(95% CI:0.600-0.661), respectively. Conclusion We have established a model to predict the 5-year risks of CVD in Chinese type 2 diabetic patients, which can be used for the early intervention of CVD among type 2 diabetic patients in residential communities.

Key words: Complication, Cardio-cerebrovascular disease, Community management, Diabetes, Prediction model

中图分类号: 

  • R587.1
[1] Association AD. Cardiovascular disease and risk management[J]. Diabetes Care, 2015, 38(suppl2): 49-57.
[2] Ruwanpathirana T, Owen A, Reid CM. Review on cardiovascular risk prediction[J]. Cardiovasc Ther, 2015, 33(2): 62-70.
[3] Shah AD, Langenberg C, Rapsomaniki E, et al. Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1.9 million people[J]. Lancet Diabetes Endocrinol, 2015, 3(2): 105-113.
[4] DAgostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study[J]. Circulation, 2008,117(6): 743-753.
[5] Dieren S Van, Beulens JWJ, Kengne AP, et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review[J]. Heart, 2012, 98(5): 360-369.
[6] Siontis GCM, Tzoulaki I, Siontis KC, et al. Comparisons of established risk prediction models for cardiovascular disease: systematic review[J]. Bmj, 2012, 344(21): e3318. doi: 10.1136/bmj.e3318.
[7] Echouffotcheugui JB, Greene SJ, Papadimitriou L, et al. Population risk prediction models for incident heart failure: a systematic review[J]. Circ Heart Fail, 2015, 8(3): 438-447.
[8] Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes(UKPDS 56)[J]. Clin Sci, 2002, 101(6): 671-679.
[9] Viti K, Stevens RJ, Adler AI, et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine[J]. Stroke J Cereb Circ, 2002, 33(7): 1776-1781.
[10] Kengne AP, Patel A, Colagiuri S, et al. The Framingham and UK Prospective Diabetes Study(UKPDS)risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation(ADVANCE)Study[J]. Diabetologia, 2010, 53(5): 821-831.
[11] Wenying Y, Juming L, Jianping W, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.
[12] Tseng CH. Mortality and causes of death in a national sample of diabetic patients in Taiwan[J]. Diabetes Care, 2005, 27(7): 1605-1609.
[13] Sullivan LM, Massaro JM, D’Agostino RB. Presentation of multivariate data for clinical use: The Framingham Study risk score functions[J]. Stat Med, 2004, 23(10): 1631-1660.
[14] 林倍倍, 陈博武, 吴柏霆, 等. 上海市社区居民糖尿病并发症及相关因素调查研究[J]. 中国预防医学杂志, 2017, 18(4): 249-253.
[15] 王博. 慢性病社区防治管理的现状和发展趋势探讨[J]. 中国卫生产业, 2016, 13(23): 193-195.
[16] Chien KL, Su TH, Chang WT, et al. Constructing the prediction model for the risk of stroke in a Chinese population: report from a cohort study in Taiwan[J]. Stroke, 2010, 41(9): 1858-1864.
[17] Chamnan P, Simmons RK, Sharp SJ, et al. Cardiovascular risk assessment scores for people with diabetes: a systematic review[J]. Diabetologia, 2009, 52(10): 2001-2014.
[18] Yang X, So WY, Kong APS, et al. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry[J]. Diabetes Care, 2007, 30(1): 65-70.
[19] Piniés JA, Fernando GC, Arteagoitia JM, et al. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine(BASCORE)[J]. Diabetologia, 2014, 57(11): 2324-2333.
[20] 孟祥英, 周勇, 汤玮, 等. ADVANCE心脑血管风险模型应用于上海市2型糖尿病患者的价值和意义[J]. 上海医学, 2015, 38(3): 226-230.
[21] 李乃适, 张念荣, 李光伟. 生活方式干预是预防2型糖尿病的重要举措[J]. 中华健康管理学杂志, 2013, 7(5): 289-291.
[22] 游小梅, 林红浪, 陈先辉, 等. 健康管理干预对社区2型糖尿病患者生活质量的效果评价[J]. 实用心脑肺血管病杂志, 2009, 17(1): 16-18.
[23] 王桂卿. 2型糖尿病患者的健康管理及对慢性并发症的影响[J]. 临床医药文献电子杂志, 2016, 3(59): 11725-11728.
[24] Tonstad S, Rosvold EO, Furu K, et al. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001[J]. J Intern Med, 2004, 255(4): 494-502.
[25] Wingard DL, Barrett-Connor EL, Ferrara A. Is insulin really a heart disease risk factor[J]. Diabetes Care, 1995, 18(9): 1299-1304.
[1] 于娜,郭情情,孙梅,盛燕,马增香,秦莹莹. 甲状腺癌术后行IVF/ICSI-ET助孕临床结局[J]. 山东大学学报(医学版), 2018, 56(9): 54-58.
[2] 田忠艳,李玉倩,刘晓田,史园园,张海庆,张霞,千新玲,尹磊,赵景志,王重建. PSMD6基因rs831571位点多态性与2型糖尿病易感性的病例对照研究[J]. 山东大学学报(医学版), 2018, 56(7): 51-56.
[3] 张众一,张淇,揭毅,周思,武海艳,臧颖,潘敬学,伍宇平,那晓东. 玉米须多糖对糖尿病小鼠肝损伤及糖代谢的影响[J]. 山东大学学报(医学版), 2018, 56(5): 52-57.
[4] 马晓,王淑娥,蔡云汐,刘厚福,何天玉,赵长峰. 全黑麦粉对实验型糖尿病小鼠降血糖的作用[J]. 山东大学学报(医学版), 2018, 56(2): 88-92.
[5] 张亮,徐敏,庄向华,娄福臣,娄能俊,吕丽,郭文娟,郑凤杰,陈诗鸿. 内质网应激与凋亡在糖尿病周围神经病变中的表达变化[J]. 山东大学学报(医学版), 2017, 55(8): 13-17.
[6] 于媛媛,王春霞,苏萍,孙苑潆,薛付忠,刘言训. 健康管理队列白内障发病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 104-107.
[7] 李敏,王春霞,夏冰,朱茜,孙苑潆,王淑康,薛付忠,贾红英. 健康管理人群脑卒中风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 93-97.
[8] 张光,王广银,吴红彦, 张红玉,王停停,李吉庆,李敏,康凤玲,刘言训,薛付忠. 健康管理人群高脂血症风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 72-76.
[9] 王春霞,许艺博,杨宁,夏冰,王萍,薛付忠. 基于健康管理队列的冠心病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 66-71.
[10] 于涛,刘焕乐,冯新,徐付印,陈亚飞,薛付忠,张成琪. 基于健康管理队列的高血压风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 61-65.
[11] 李吉庆,赵焕宗,宋炳红,张理纯,李向一,陈亚飞,王萍,薛付忠. 基于健康管理队列的心血管事件风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 56-60.
[12] 苏萍,杨亚超,杨洋,季加东,阿力木·达依木,李敏,薛付忠,刘言训. 健康管理人群2型糖尿病发病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 82-86.
[13] 孙苑潆,杨亚超,曲明苓,陈雁敏,李敏,王淑康,薛付忠,刘云霞. 健康管理人群代谢综合征发病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 87-92.
[14] 周苗,夏同耀,孙爱玲,李明,申振伟,卞伟玮,蒋正,康凤玲,柳晓涓,薛付忠,刘静. 健康管理人群慢性肾脏病风险预测模型[J]. 山东大学学报(医学版), 2017, 55(6): 98-103.
[15] 卢晔,崔会芳,陈旭君,黄溢华,吴奕群,黄建隆,陈辉民,熊贤俊,陈明红. 冷冻技术在呼吸介入治疗中的应用进展及其并发症防治浅析[J]. 山东大学学报(医学版), 2017, 55(4): 19-22.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 李 慧,徐贵发,刘跟生,张 洁,周湘盈,丰佃娟. 人体血清载脂蛋白A-IV水平与肥胖、瘦素的相关性探讨[J]. 山东大学学报(医学版), 2007, 45(1): 6 -09 .
[2] 高立芬,孙汶生,马春红,张利宁,梁晓红,王晓燕,郭春,陈有海 . pcDNA3-HBV瞬时转染对树突状细胞的影响[J]. 山东大学学报(医学版), 2007, 45(4): 325 -328 .
[3] 肖水清,杜毅,韩晶 . 正畸治疗过程中龈沟液内细菌变化的研究[J]. 山东大学学报(医学版), 2006, 44(5): 508 -510 .
[4] 毕爱玲,高建新,刘克敬,周玉琴. 三磷酸腺苷诱导体外培养的胚胎大鼠皮层神经细胞凋亡[J]. 山东大学学报(医学版), 2006, 44(12): 1194 -1196 .
[5] 薛文君,王海涛,王明青 . 预构扩张皮瓣的实验研究[J]. 山东大学学报(医学版), 2006, 44(12): 1233 -1237 .
[6] 张纪庆,王志刚,丁璇,冀勇,沈寻,韩磊. 脑动静脉畸形癫痫的相关血管构筑学及栓塞治疗研究[J]. 山东大学学报(医学版), 2006, 44(12): 1238 -1240 .
[7] 颜军昊,陈子江,李媛,胡京美,高姗姗. 体外受精周期中来源于单原核受精卵胚胎性染色体分析[J]. 山东大学学报(医学版), 2006, 44(6): 545 -548 .
[8] 孙建英,冯延秋,迟兆富,吴伟 . 海人酸致痫大鼠海马CA3区神经元线粒体损伤及妥泰的保护作用[J]. 山东大学学报(医学版), 2006, 44(6): 556 -559 .
[9] 王旭平,赵玲,冯玉新,商林珊,刘金成,曹伟朋,朱晓音,辛华. 绞股蓝总苷对谷氨酸诱导的胎鼠大脑皮层神经元氧化性损伤保护机制的研究[J]. 山东大学学报(医学版), 2006, 44(6): 564 -567 .
[10] 费 玲,隋树建,任满意,许复郁,刘伟华,杜贻萌 . 实验性兔动脉粥样硬化病变中TRAIL、DR5的表达及意义[J]. 山东大学学报(医学版), 2007, 45(2): 135 -138 .